As we age, the risk of retinal disorders increases due to cumulative oxidative stress, reduced cellular energy production, decreased blood flow, and natural degeneration of retinal tissues. Age-related macular degeneration (AMD) is one example of a condition that can gradually impair central vision. Our proprietary Quantum Dot (QD) ophthalmic lens is designed to deliver targeted passive photo-biomodulation (PBM) light therapy to the central and peripheral retina while maintaining over 80% visible light transmission. By supporting retinal cellular energy production and mitochondrial function, this proprietary ophthalmic lens is intended to help promote retinal health, comfort, and long-term visual wellness.